课题基金 / 基金详情

Optimization of nasal administering conditions with the formulation development.

Optimization of nasal administering conditions with the formulation development.
随着制剂开发优化鼻腔给药条件。
批准号:
20790153
负责人:
FURUBAYASHI Tomoyuki
金额:
$2.5万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2009

项目摘要

项目成果

FURUBAYASHI Tomoyuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In order to establish the evaluation system to optimize the nasal formulation, drug absorption from the powder formulations following nasal administration was investigated. The balance of the nasal residence of the drug and the dissolution from powder in the nasal cavity was an important factor to determine the nasal drug absorption. This finding suggested the feasibility that the nasal absorption is improved by controlling the nasal residence time of powder formulation. On the other hand, it was clarified that the transcellular permeability of the drug is dependent on the origin of the cell used for in vitro study. This finding would lead to renewing and improving the estimation system for nasal drug absorption, which had been previously established.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间: 2008
期刊:
影响因子: --
作者: [Ishizaki J, Waki Y, Takahashi-Nishioka T, Yokogawa K, Miyamoto KI, 中村瑞穂, 井上大輔]
通讯作者: 井上大輔
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [鈴木俊宏, 西尾和人, 兎川忠靖, 菅原佳奈子, 櫻庭均, 古林呂之]
通讯作者: 古林呂之
薬物の経鼻吸収性評価システムの開発~粘性製剤からの薬物吸収性評価~
药物经鼻吸收评价系统的开发 - 粘稠制剂的药物吸收评价 -
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [Tatsuo Takahashi, et al., 上家潤一, 古林呂之]
通讯作者: 古林呂之
鼻腔内繊毛運動評価系の確率及び繊毛運動と経鼻吸収性との関係
鼻内纤毛运动概率评价系统及纤毛运动与鼻吸收的关系
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [佐藤和子, 地主拓也, 巨勢典子, 西村友宏, 崔吉道, 中島恵美, 井上大輔]
通讯作者: 井上大輔
14
    tudy of the mechanism of drug nasal absorption and optimization of the drug delivery to the cervical lymph node through the nasal membrane.
    • 批准号:
      22590161
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2010
    • 负责人:
      FURUBAYASHI Tomoyuki
    • 依托单位:
    海外基金